Denise Mafra, Marcia Ribeiro, Larissa Fonseca, Bruna Regis, Ludmila F M F Cardozo, Henrique Fragoso Dos Santos, Hugo Emiliano de Jesus, Junia Schultz, Paul G Shiels, Peter Stenvinkel, Alexandre Rosado
Journal: Anaerobe 2022;77():102629
PMID: 35985606
Archaea comprise a unique domain of organisms with distinct biochemical and genetic differences from bacteria. Methane-forming archaea, methanogens, constitute the predominant group of archaea in the human gut microbiota, with Methanobrevibacter smithii being the most prevalent. However, the effect of methanogenic archaea and their methane production on chronic disease remains controversial. As perturbation of the microbiota is a feature of chronic conditions, such as cardiovascular disease, neurodegenerative diseases and chronic kidney disease, assessing the influence of archaea could provide a new clue to mitigating adverse effects associated with dysbiosis. In this review, we will discuss the putative role of archaea in the gut microbiota in humans and the possible link to chronic diseases.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Full Text Sources:
Research Materials:
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.